Emtricitabine And Tenofovir Alafenamide + Rifampin Interaction

Majorinteraction on record

Description

Decreases TAF concentration. Coadministration with DESCOVY is not recommended.

Mechanism

P-gp and BCRP induction leading to decreased TAF absorption

Source: NLP:emtricitabine and tenofovir alafenamide